Page last updated: 2024-11-04

semustine and Preleukemia

semustine has been researched along with Preleukemia in 2 studies

Semustine: 4-Methyl derivative of LOMUSTINE; (CCNU). An antineoplastic agent which functions as an alkylating agent.
semustine : An organochlorine compound that is urea in which the two hydrogens on one of the amino groups are replaced by nitroso and 2-chloroethyl groups and one hydrogen from the other amino group is replaced by a 4-methylcyclohexyl group.

Preleukemia: Conditions in which the abnormalities in the peripheral blood or bone marrow represent the early manifestations of acute leukemia, but in which the changes are not of sufficient magnitude or specificity to permit a diagnosis of acute leukemia by the usual clinical criteria.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boice, JD1
Greene, MH1
Killen, JY1
Ellenberg, SS1
Keehn, RJ1
McFadden, E1
Chen, TT1
Fraumeni, JF1
Calabresi, P1

Trials

1 trial available for semustine and Preleukemia

ArticleYear
Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU).
    The New England journal of medicine, 1983, Nov-03, Volume: 309, Issue:18

    Topics: Acute Disease; Aged; Clinical Trials as Topic; Combined Modality Therapy; Female; Gastrointestinal N

1983

Other Studies

1 other study available for semustine and Preleukemia

ArticleYear
Leukemia after cytotoxic chemotherapy--a pyrrhic victory?
    The New England journal of medicine, 1983, Nov-03, Volume: 309, Issue:18

    Topics: Acute Disease; Antineoplastic Agents; Humans; Leukemia; Neoplasms; Preleukemia; Semustine

1983